Zai Lab grabs top AstraZeneca cancer executive to prep its first drug rollout

5th June 2018 Uncategorised 0

China’s Zai Lab is revving up for its first drug launch, and it’s brought on an AstraZeneca oncology executive to lead the charge. His first task? Building up a commercial team to roll out Zejula, the PARP inhibitor it licensed from Tesaro, in Hong Kong.

More: Zai Lab grabs top AstraZeneca cancer executive to prep its first drug rollout
Source: fierce